Evidence map›Paper›PMID 19328544›Full record

ArticleBiomaterials2009

The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds.

Bing Li, Jeffrey M Davidson, Scott A Guelcher

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Biomaterials, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 150 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Drug delivery systems for wound healing.Current pharmaceutical biotechnology · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Bing LiDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 3723, USA. bing.li@vanderbilt.edu
Jeffrey M Davidson
Scott A Guelcher
Vanderbilt University · US

Funding

UV, APOPTOSIS, PROTEIN PHOSPHATASE AND SKIN DISEASEP30AR041943 · NIAMS · VANDERBILT UNIVERSITY · PI MCCAWLEY, LISA JOY · 1994 to 2008
$5.3M
ELASTIN AND COLLAGEN IN THE AGING PROCESSR01AG006528 · NIA · VANDERBILT UNIVERSITY · PI DAVIDSON, JEFFREY M. · 1986 to 2011
$2.9M
NIAMS NIH HHS AR041943NIA NIH HHS AG-06528NIA NIH HHS R01 AG006528
6 · The paper itself

Abstract

A key tenet of tissue engineering is the principle that the scaffold can perform the dual roles of biomechanical and biochemical support through presentation of the appropriate mediators to surrounding tissue. While growth factors have been incorporated into scaffolds to achieve sustained release, there are a limited number of studies investigating release of biologically active molecules from reactive two-component polymers, which have potential application as injectable delivery systems. In this study, we report the sustained release of platelet-derived growth factor (PDGF) from a reactive two-component polyurethane. The release of PDGF was bi-phasic, characterized by an initial burst followed by a period of sustained release for up to 21 days. Despite the potential for amine and hydroxyl groups in the protein to react with the isocyanate groups in the reactive polyurethane, the in vitro bioactivity of the released PDGF was largely preserved when added as a lyophilized powder. PUR/PDGF scaffolds implanted in rat skin excisional wounds accelerated wound healing relative to the blank PUR control, resulting in almost complete healing with reepithelization at day 14. The presence of PDGF attracted both fibroblasts and mononuclear cells, significantly accelerating degradation of the polymer and enhancing formation of new granulation tissue as early as day 3. The ability of reactive two-component PUR scaffolds to promote new tissue formation in vivo through local delivery of PDGF may present compelling opportunities for the development of novel injectable therapeutics.

Indexed as

GelatinPlatelet-Derived Growth FactorSkin3T3 CellsAnimalsBecaplerminBiocompatible MaterialsCell ProliferationHeparinLactic AcidMaleMaterials TestingMiceMicrospheresPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerBecaplerminBiocompatible MaterialsGelatinHeparinLactic AcidPlatelet-Derived Growth FactorPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPolyurethanesProto-Oncogene Proteins c-sis

Identifiers

PMID19328544
PMCPMC2683181
OpenAlexW2014550800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.